Search

Christopher Upton

Examiner (ID: 12246, Phone: (571)272-1169 , Office: P/1778 )

Most Active Art Unit
1778
Art Unit(s)
1776, 1308, 1778, 1724, 1306, 1797
Total Applications
3146
Issued Applications
2580
Pending Applications
123
Abandoned Applications
451

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13987297 [patent_doc_number] => 20190062806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => NUCLEIC ACID PRESERVATION SOLUTION AND METHODS OF MANUFACTURE AND USE [patent_app_type] => utility [patent_app_number] => 16/176210 [patent_app_country] => US [patent_app_date] => 2018-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18676 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16176210 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/176210
Nucleic acid preservation solution and methods of manufacture and use Oct 30, 2018 Issued
Array ( [id] => 13958499 [patent_doc_number] => 20190055593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-21 [patent_title] => SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS [patent_app_type] => utility [patent_app_number] => 16/175353 [patent_app_country] => US [patent_app_date] => 2018-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58564 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16175353 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/175353
SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS Oct 29, 2018 Abandoned
Array ( [id] => 13929781 [patent_doc_number] => 20190048406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-14 [patent_title] => Oxidising Agent for Modified Nucleotides [patent_app_type] => utility [patent_app_number] => 16/171744 [patent_app_country] => US [patent_app_date] => 2018-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9877 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16171744 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/171744
Oxidising Agent for Modified Nucleotides Oct 25, 2018 Abandoned
Array ( [id] => 13929783 [patent_doc_number] => 20190048407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-14 [patent_title] => SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS [patent_app_type] => utility [patent_app_number] => 16/172369 [patent_app_country] => US [patent_app_date] => 2018-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58520 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16172369 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/172369
SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS Oct 25, 2018 Abandoned
Array ( [id] => 16344002 [patent_doc_number] => 20200308652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => DIAGNOSIS AND/OR PROGNOSIS OF HER2-DEPENDENT CANCER USING MOESIN AS A BIOMARKER [patent_app_type] => utility [patent_app_number] => 16/758644 [patent_app_country] => US [patent_app_date] => 2018-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5636 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758644 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/758644
DIAGNOSIS AND/OR PROGNOSIS OF HER2-DEPENDENT CANCER USING MOESIN AS A BIOMARKER Oct 23, 2018 Abandoned
Array ( [id] => 16606203 [patent_doc_number] => 10907198 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-02 [patent_title] => Assay systems for genetic analysis [patent_app_type] => utility [patent_app_number] => 16/159588 [patent_app_country] => US [patent_app_date] => 2018-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 11 [patent_no_of_words] => 35071 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 450 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16159588 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/159588
Assay systems for genetic analysis Oct 11, 2018 Issued
Array ( [id] => 14214735 [patent_doc_number] => 20190119752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-25 [patent_title] => ASSAY SYSTEMS FOR GENETIC ANALYSIS [patent_app_type] => utility [patent_app_number] => 16/159575 [patent_app_country] => US [patent_app_date] => 2018-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31133 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16159575 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/159575
Assay systems for genetic analysis Oct 11, 2018 Issued
Array ( [id] => 14073055 [patent_doc_number] => 20190085415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-21 [patent_title] => Microarray Based Multiplex Pathogen Analysis and Uses Thereof [patent_app_type] => utility [patent_app_number] => 16/158276 [patent_app_country] => US [patent_app_date] => 2018-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27006 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 416 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16158276 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/158276
Microarray based multiplex pathogen analysis and uses thereof Oct 10, 2018 Issued
Array ( [id] => 14073053 [patent_doc_number] => 20190085414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-21 [patent_title] => Microarray Based Multiplex Pathogen Analysis and Uses Thereof [patent_app_type] => utility [patent_app_number] => 16/158181 [patent_app_country] => US [patent_app_date] => 2018-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25983 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 259 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16158181 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/158181
Microarray based multiplex pathogen analysis and uses thereof Oct 10, 2018 Issued
Array ( [id] => 14102943 [patent_doc_number] => 20190093147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-28 [patent_title] => PURIFICATION PROCESS OF NASCENT DNA [patent_app_type] => utility [patent_app_number] => 16/155421 [patent_app_country] => US [patent_app_date] => 2018-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17320 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16155421 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/155421
PURIFICATION PROCESS OF NASCENT DNA Oct 8, 2018 Abandoned
Array ( [id] => 14073021 [patent_doc_number] => 20190085398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-21 [patent_title] => Compositions and Methods for Diagnosing Diseases and Disorders Associated with Beta Cell Death [patent_app_type] => utility [patent_app_number] => 16/140592 [patent_app_country] => US [patent_app_date] => 2018-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15898 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16140592 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/140592
Compositions and Methods for Diagnosing Diseases and Disorders Associated with Beta Cell Death Sep 24, 2018 Abandoned
Array ( [id] => 13829101 [patent_doc_number] => 20190018035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => HIV VIRAL LOAD TESTING [patent_app_type] => utility [patent_app_number] => 16/133784 [patent_app_country] => US [patent_app_date] => 2018-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7700 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133784 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/133784
HIV VIRAL LOAD TESTING Sep 17, 2018 Pending
Array ( [id] => 17905756 [patent_doc_number] => 11459602 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-04 [patent_title] => Method for generating double stranded DNA libraries and sequencing methods for the identification of methylated cytosines [patent_app_type] => utility [patent_app_number] => 16/133842 [patent_app_country] => US [patent_app_date] => 2018-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 42521 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133842 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/133842
Method for generating double stranded DNA libraries and sequencing methods for the identification of methylated cytosines Sep 17, 2018 Issued
Array ( [id] => 16298131 [patent_doc_number] => 20200283854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => METHOD FOR METHYLATION ANALYSIS [patent_app_type] => utility [patent_app_number] => 16/645749 [patent_app_country] => US [patent_app_date] => 2018-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33505 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16645749 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/645749
METHOD FOR METHYLATION ANALYSIS Sep 13, 2018 Abandoned
Array ( [id] => 13794039 [patent_doc_number] => 20190010558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-10 [patent_title] => METHOD FOR DETERMINING THE RISK OF RECURRENCE OF AN ESTROGEN RECEPTOR-POSITIVE AND HER2-NEGATIVE PRIMARY MAMMARY CARCINOMA UNDER AN ENDOCRINE THERAPY [patent_app_type] => utility [patent_app_number] => 16/124915 [patent_app_country] => US [patent_app_date] => 2018-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8928 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16124915 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/124915
METHOD FOR DETERMINING THE RISK OF RECURRENCE OF AN ESTROGEN RECEPTOR-POSITIVE AND HER2-NEGATIVE PRIMARY MAMMARY CARCINOMA UNDER AN ENDOCRINE THERAPY Sep 6, 2018 Abandoned
Array ( [id] => 16422257 [patent_doc_number] => 20200347455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-05 [patent_title] => Clear Cell Renal Cell Carcinoma Biomarkers [patent_app_type] => utility [patent_app_number] => 16/642430 [patent_app_country] => US [patent_app_date] => 2018-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21341 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642430 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/642430
Clear Cell Renal Cell Carcinoma Biomarkers Sep 4, 2018 Abandoned
Array ( [id] => 16901212 [patent_doc_number] => 20210180128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => METHOD TO CONFIRM VARIANTS IN NGS PANEL TESTING BY SNP GENOTYPING [patent_app_type] => utility [patent_app_number] => 16/643197 [patent_app_country] => US [patent_app_date] => 2018-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15499 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16643197 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/643197
METHOD TO CONFIRM VARIANTS IN NGS PANEL TESTING BY SNP GENOTYPING Aug 27, 2018 Abandoned
Array ( [id] => 14439855 [patent_doc_number] => 20190177800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-13 [patent_title] => METHODS AND COMPOSITIONS FOR LABELING CELLS [patent_app_type] => utility [patent_app_number] => 16/107685 [patent_app_country] => US [patent_app_date] => 2018-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33690 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16107685 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/107685
METHODS AND COMPOSITIONS FOR LABELING CELLS Aug 20, 2018 Abandoned
Array ( [id] => 14185923 [patent_doc_number] => 20190112666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-04-18 [patent_title] => Methods for evaluating tumor cell spheroids using 3d microfluidic cell culture device [patent_app_type] => utility [patent_app_number] => 15/999230 [patent_app_country] => US [patent_app_date] => 2018-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34248 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15999230 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/999230
Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture device Aug 16, 2018 Issued
Array ( [id] => 13590847 [patent_doc_number] => 20180346972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-06 [patent_title] => STABLE NANOREPORTERS [patent_app_type] => utility [patent_app_number] => 16/103369 [patent_app_country] => US [patent_app_date] => 2018-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32700 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16103369 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/103369
STABLE NANOREPORTERS Aug 13, 2018 Abandoned
Menu